Verapamil for type 1 diabetes

Recent research has shed light on a potential new avenue to reduce insulin requirements for people with type 1 diabetes. An estimated 1.2 million Australians...

Pharmacists on the front line: Approaches to mental illness

0
Australia’s run of catastrophic summer bushfires followed by the COVID-19 pandemic has taken a grim toll on the nation’s mental health.

Highlights from WA’s Annual Therapeutic Update

0
Western Australian pharmacists were treated to a program chock-full of clinical advice for grappling with some of today’s key health issues at PSA’s 2021 WA Annual Therapeutic Update held on 8 May.

Pharmacists honoured at annual awards

0
Pharmacists in Queensland and Tasmania have been recognised for their contributions to the health of the community, with awards presented at two events at...

Chronic lymphocytic leukaemia and the pharmacist

0
The management of chronic lymphocytic leukaemia has changed dramatically in the last decade with the introduction of novel oral immune-targeted therapies. There are increasing opportunities for pharmacists to contribute to the multidisciplinary care of patients with CLL to ensure medicine safety and best patient outcomes.

Sepsis: recognition and management

0
Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. It is a medical emergency which, if left untreated, progresses to septic shock, multi-organ failure and death.